Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medicenna Therapeutics Corp (MDNAF)

Medicenna Therapeutics Corp (MDNAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medicenna Therapeutics Corp 2 BLOOR STREET WEST 7TH FLOOR Toronto A6 M4W 3E2 CAN

www.medicenna.com Employees: 18 P: 416-648-5555

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Medicenna Therapeutics Corp is a clinical stage immuno-oncology company. It is engaged in developing engineered versions of IL-2, IL4 and IL13 cytokines called Superkines and Empowered Cytokines ECs for the treatment of cancer. Medicenna Therapeutics Corp is based in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 50,047
Enterprise Value, $K 32,197
Shares Outstanding, K 83,411
Float, K 55,802
% Float 66.90%
Short Interest, K 585
Short Float 0.70%
Days to Cover 3.86
Short Volume Ratio 0.41
% of Insider Shareholders 33.10%
% of Institutional Shareholders 35.85%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -8,480 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,540 K
EBIT, $ -15,620 K
EBITDA, $ -15,580 K

Growth:

1-Year Return -33.11%
3-Year Return -17.83%
5-Year Return -84.62%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 10.53%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 11/12/25
Next Earnings Date 02/11/26 [--]
Earnings Per Share ttm -0.18
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MDNAF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -132.93%
Return-on-Assets % -80.52%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.70
Book Value/Share 0.09
Interest Coverage -0.98
60-Month Beta 1.81
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar